Impact of COVID-19 on the performance of a radiation oncology department at a major comprehensive cancer centre in Poland during the first ten weeks of the epidemic.
Antibodies
COVID19
Cancer incidence
Radiotherapy
qPCR
Journal
Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
ISSN: 1507-1367
Titre abrégé: Rep Pract Oncol Radiother
Pays: Poland
ID NLM: 100885761
Informations de publication
Date de publication:
Historique:
received:
16
07
2020
accepted:
06
08
2020
pubmed:
25
8
2020
medline:
25
8
2020
entrez:
25
8
2020
Statut:
ppublish
Résumé
The outbreak of SARS-CoV-2 coronavirus rapidly altered radiotherapy service delivery around the world. The main objective of this study was to assess the impact of precautionary measures implemented in response to the COVID-19 pandemic on the performance of a radiation oncology departments and on mitigation the risk of COVID-19 contagion between and among patients and staff. The study period was from March 15 until May 22, 2020. We evaluated total number of patients irradiated and those who initiated treatments, taking into account tumours localisations. We assessed the relationship of potential risk of contagion with patients' domiciles locations in regions with high number of COVID19 case. The number of patients treated with radiotherapy during the study period decreased due to precautionary measures. After five weeks, the number of radiotherapy treatments began to increase. Just over half of the radiotherapy patients (53.5%) treated at the GPCC reside in the city of Poznan or in one of the ten surrounding counties where COVID19 incidence was low and reached at the end of the study period cumulative number of cases n = 204. The precautionary measures were effective qRT-PCR tests were performed in 1545 individuals (patients and hospital staff) revealing four staff members and none patient with a positive PCR result. Immunoglobulin testing was performed in 1132 individuals (patients and hospital staff). A total of 63 individuals were positive for antibodies.
Identifiants
pubmed: 32837336
doi: 10.1016/j.rpor.2020.08.001
pii: S1507-1367(20)30109-7
pmc: PMC7429079
doi:
Types de publication
Journal Article
Langues
eng
Pagination
820-827Informations de copyright
© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights reserved.
Références
Clin Oncol (R Coll Radiol). 2020 May;32(5):279-281
pubmed: 32241520
Rep Pract Oncol Radiother. 2020 Jul-Aug;25(4):632-636
pubmed: 32549796
Radiother Oncol. 2020 Jul;148:213-215
pubmed: 32342861
Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627
pubmed: 32302681
Radiother Oncol. 2015 Jul;116(1):38-44
pubmed: 25981052
Radiother Oncol. 2020 May;146:223-229
pubmed: 32342863
Rep Pract Oncol Radiother. 2014 Jul 09;19(5):296-300
pubmed: 25184053
Radiother Oncol. 2020 Jul;148:203-210
pubmed: 32342870
Radiother Oncol. 2015 Jul;116(1):45-50
pubmed: 26002304
Adv Radiat Oncol. 2020 Apr 01;5(4):582-588
pubmed: 32292842
Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):597-599
pubmed: 32199941
Prostate Cancer Prostatic Dis. 2020 Sep;23(3):398-406
pubmed: 32690870
Rep Pract Oncol Radiother. 2013 Mar 13;18(3):159-72
pubmed: 24416548